4 Results for "

MARK-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "MARK-IN-1" in MCE Product Catalog:

Cat. No.: HY-101933
CAS No.: 1109283-93-3
Purity:  98.48%
Target:  

AMPK

Research Areas:  

Neurological Disease

MARK-IN-1 is a potent microtubule affinity regulating kinase (MARK) inhibitor with an IC50 of <0.25 nM.
loading...
    loading...
Cat. No.: HY-120877
CAS No.: 1456858-57-3
Purity:  99.74%
Research Areas:  

Cancer

MRT199665 is a potent and ATP-competitive, selective MARK/SIK/AMPK inhibitor with IC50s of 2/2/3/2 nM, 10/10 nM, and 110/12/43 nM for MARK1/MARK2/MARK3/MARK14, AMPKα1/AMPKα2, and SIK1/SIK2/SIK3, respectively [1]. MRT199665 causes apoptosis in MEF2C-activated human acute myeloid leukemias (AML) cells . MRT199665 inhibits the phosphorylation of SIK substrate CRTC3 at S370 .
loading...
    loading...
Cat. No.: HY-W070306
CAS No.: 1207836-10-9
PDK1-IN-1 (Compound 2-11) is a PDK1 inhibitor. PDK1-IN-1 is also useful as inhibitor of other kinases such as FGFR3, NTRK3, RP-S6K and WEE1. PDK1-IN-1 selectively inhibits microtubule affinity regulating kinase (MARK). PDK1-IN-1 can be used for researches of myeloproliferative disorders, cancer and Alzheimer's disease [1].
loading...
    loading...
Cat. No.: HY-120877A
Purity:  98.70%
Research Areas:  

Cancer

(R)-MRT199665 is an isomer of MRT199665 (HY-120877). MRT199665 is a potent and ATP-competitive, selective MARK/SIK/AMPK inhibitor with IC50s of 2/2/3/2 nM, 10/10 nM, and 110/12/43 nM for MARK1/MARK2/MARK3/MARK14, AMPKα1/AMPKα2, and SIK1/SIK2/SIK3, respectively. MRT199665 causes apoptosis in MEF2C-activated human acute myeloid leukemias (AML) cells. MRT199665 inhibits the phosphorylation of SIK substrate CRTC3 at S370 [1] .
loading...
    loading...